Skip to content
OpenCapital
Get started

AbCellera Biologics Inc. ABCL Q1 2026 earnings

Reported May 11, 2026 · After market close

Revenue$8.3MBeat by $2.9M
EPS-$0.14Beat by $0.08
Revenue estimate$5.4M
EPS estimate-$0.22

Next report

Aug 5, 2026 (In 1 week)
Revenue estimate$7.8M
EPS estimate-$0.12

Financials

Q1 2026

Income statement

See full
Revenue$8.3M+96.3%
Operating income-$57.5M+8.2%
Net income-$43.2M+5.4%
EPS (diluted)-$0.14+6.7%

Balance sheet

See full
Cash & equivalents$102.1M-44.6%
Total debt$140.2M+107%
Total equity$938.1M-8.3%
Total assets$1.3B-2.8%

Cash flow

See full
Operating cash flow-$33.5M-190%
CapEx$3.8M-64.0%
Free cash flow-$37.4M-68.3%

Valuation & ratios

Valuation

as of 07/28/26
See full
Market cap$1.6B+9.2%
Enterprise value$1.64B+9.9%
P/S20.2×-24.4×

Profitability

See full
Operating margin-267.6%-120pp
Net margin-181.7%-77.9pp
FCF margin-238.9%-90.9pp

Returns & leverage

See full
Return on equity-14.7%-0.8pp
Debt / equity0.1×+0.1×
Current ratio14.1×+3.9×

Versus estimates

Revenue

Q1 2026$8.3MBeat by $2.9M
Q4 2025$44.9MBeat by $38.2MQ3 2025$9.0MBeat by $2.6MQ2 2025$17.1MBeat by $10.7MQ1 2025$4.2MMiss by $3.1MQ4 2024$5.1MMiss by $2.5M

Diluted EPS

Q1 2026-$0.14Beat by $0.08
Q4 2025-$0.03Beat by $0.15Q3 2025-$0.19Miss by $0.02Q2 2025-$0.12Beat by $0.05Q1 2025-$0.15Beat by $0.02Q4 2024-$0.11Beat by $0.04

Ask the moment AbCellera Biologics Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did AbCellera Biologics Inc. report Q1 2026 earnings?
AbCellera Biologics Inc. (ABCL) reported Q1 2026 earnings on May 11, 2026 after market close.
What were AbCellera Biologics Inc.'s Q1 2026 revenue and EPS?
AbCellera Biologics Inc. reported revenue of $8.3M and eps of $-0.14 for Q1 2026.
Did AbCellera Biologics Inc. beat estimates in Q1 2026?
Revenue beat the consensus estimate of $5.4M by $2.9M. EPS beat the consensus estimate of $-0.22 by $0.08.
How did AbCellera Biologics Inc.'s Q1 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 96.3% from $4.2M a year earlier and eps grew 6.7% from $-0.15.
Where can I find AbCellera Biologics Inc.'s Q1 2026 SEC filings?
You can read the 8-K earnings release (0001703057-26-000027) and the 10-Q periodic report (0001703057-26-000028) directly on SEC EDGAR. The filing index links above go to sec.gov.